Lobeglitazone Completed Phase 1 Trials for Liver Dysfunction

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT02005744A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function